Published in J Hypertens on September 01, 1996
Home blood pressure monitoring: its effect on the management of hypertension in general practice. Br J Gen Pract (1999) 1.44
Changes in left ventricular structure and function in patients with white coat hypertension: cross sectional survey. BMJ (1998) 1.19
Modern approaches to blood pressure measurement. Occup Environ Med (2000) 1.19
Diagnosis and management of patients with white-coat and masked hypertension. Nat Rev Cardiol (2011) 1.03
Pressure for change: unresolved issues in blood pressure measurement. Br J Gen Pract (1999) 0.98
Blood pressure control and primary prevention of stroke: summary of the recent clinical trial data and meta-analyses. Curr Hypertens Rep (2013) 0.88
Should white-coat hypertension in diabetes be treated? Pro. Diabetes Care (2009) 0.80
The Blood Pressure "Uncertainty Range" - a pragmatic approach to overcome current diagnostic uncertainties (II). Curr Control Trials Cardiovasc Med (2005) 0.78
White-coat hypertension. J Hypertens (1997) 0.78
Coronary flow reserve is preserved in white-coat hypertension. Heart (2005) 0.78
Survey of white coat hypertension. Definition differs from others. BMJ (1999) 0.78
Personalised Single-Pill Combination Therapy in Hypertensive Patients: An Update of a Practical Treatment Platform. High Blood Press Cardiovasc Prev (2017) 0.75
Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens (1995) 2.58
Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate. Lancet (1983) 2.18
Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation (2001) 2.08
European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens (2010) 2.06
Blood-pressure control in the hypertensive population. Lancet (1997) 2.05
Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system. J Hypertens (2007) 2.01
Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol (2001) 1.94
Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens (2003) 1.93
Studies of the absorption and removal of propranolol in hypertensive patients during therapy. Circulation (1975) 1.92
A sympathetic reflex elicited by experimental coronary occlusion. Am J Physiol (1969) 1.89
Alerting reaction and rise in blood pressure during measurement by physician and nurse. Hypertension (1987) 1.80
The Hypertension Optimal Treatment (HOT) Study: 24-month data on blood pressure and tolerability. Blood Press (1997) 1.76
Compliance to hypertension guidelines in clinical practice: a multicentre pilot study in Italy. J Hum Hypertens (2002) 1.75
Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res (1983) 1.74
Seasonal variations in home and ambulatory blood pressure in the PAMELA population. Pressione Arteriose Monitorate E Loro Associazioni. J Hypertens (1998) 1.73
The Hypertension Optimal Treatment (HOT) Study--patient characteristics: randomization, risk profiles, and early blood pressure results. Blood Press (1994) 1.70
Evaluation of the baroreceptor-heart rate reflex by 24-hour intra-arterial blood pressure monitoring in humans. Hypertension (1988) 1.69
Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT study. Hypertension Optimal Treatment. J Hypertens (2000) 1.48
Hypotensive and renin-suppressing activities of propranolol in hypertensive patients. Clin Sci Mol Med Suppl (1975) 1.46
The 1996 report of a World Health Organization expert committee on hypertension control. J Hypertens (1996) 1.45
Early 24-hour blood pressure elevation in normotensive subjects with parental hypertension. Hypertension (1990) 1.43
Metabolic syndrome and biventricular hypertrophy in essential hypertension. J Hum Hypertens (2008) 1.39
Target organ damage and non-dipping pattern defined by two sessions of ambulatory blood pressure monitoring in recently diagnosed essential hypertensive patients. J Hypertens (2001) 1.36
Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens (2001) 1.36
High prevalence of cardiac and extracardiac target organ damage in refractory hypertension. J Hypertens (2001) 1.35
Guidelines for the use of self-blood pressure monitoring: a summary report of the First International Consensus Conference. Groupe Evaluation & Measure of the French Society of Hypertension. J Hypertens (2000) 1.29
Comparison of the antihypertensive effect of urapidil and metoprolol in hypertension. Eur J Clin Pharmacol (1986) 1.24
Low glomerular filtration in the population: prevalence, associated disorders, and awareness. Kidney Int (2006) 1.22
The variable-pressure neck-chamber method for studying the carotid baroreflex in man. Clin Sci Mol Med (1977) 1.20
Natriuretic effect of calcium antagonists. J Cardiovasc Pharmacol (1985) 1.17
Functional role of renal afferents. Physiol Rev (1991) 1.13
Patterns of hypertension management in Italy: results of a pharmacoepidemiological survey on antihypertensive therapy. Scientific Committee of the Italian Pharmacoepidemiological Survey on Antihypertensive Therapy. J Hypertens (2000) 1.13
Felodipine, a new vasodilating drug: blood pressure, cardiac, renal, and humoral effects in hypertensive patients. J Cardiovasc Pharmacol (1984) 1.12
Indexation of left ventricular mass to body surface area and height to allometric power of 2.7: is the difference limited to obese hypertensives? J Hum Hypertens (2009) 1.11
Comparison of cardiovascular, renal, and humoral effects of acute administration of two calcium channel blockers in normotensive and hypertensive subjects. J Cardiovasc Pharmacol (1982) 1.10
Clinical results of the Verapamil inHypertension and Atherosclerosis Study. VHAS Investigators. J Hypertens (1997) 1.09
Control of blood pressure by carotid sinus baroreceptors in human beings. Am J Cardiol (1979) 1.06
Baseline reproducibility of B-mode ultrasonic measurement of carotid artery intima-media thickness: the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens (2000) 1.06
ESH-ESC guidelines for the management of hypertension. Herz (2006) 1.05
Circulatory reflexes from carotid and extracarotid baroreceptor areas in man. Circ Res (1977) 1.05
Antihypertensive and renal effects of orally administered verapamil. Eur J Clin Pharmacol (1980) 1.02
Benefits and cost-effectiveness of antihypertensive therapy. The actuarial versus the intervention trial approach. J Hypertens (1996) 1.02
Hemodynamic factors changing blood flow velocity waveform and profile in normal human brachial artery. Angiology (1985) 1.02
Modification of arterial baroreflexes by captopril in essential hypertension. Am J Cardiol (1982) 1.02
Lack of placebo effect on ambulatory blood pressure. Am J Hypertens (1995) 1.00
Blood pressure variability in man: its relation to high blood pressure, age and baroreflex sensitivity. Clin Sci (Lond) (1980) 1.00
Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly. Arch Intern Med (1998) 0.99
Serum uric acid for short-term prediction of cardiovascular disease incidence in the Gubbio population Study. Acta Cardiol (2001) 0.98
Neural mechanisms in life-threatening arrhythmias. Am Heart J (1980) 0.97
The use of drug concentration measurements in studies of the therapeutic response to propranolol. Postgrad Med J (1976) 0.96
Nicorandil, a new vasodilator drug, in patients with essential hypertension. J Hypertens Suppl (1989) 0.96
Mechanisms of renal release of renin by electrical stimulation of the brainstem in the cat. Circ Res (1974) 0.95
Ambulatory and home blood pressure normality in the elderly: data from the PAMELA population. Hypertension (1997) 0.95
Awareness of hypertension guidelines in primary care: results of a regionwide survey in Italy. J Hum Hypertens (2003) 0.95
Home blood pressure measurement and its relationship with blood pressure control in a large selected hypertensive population. J Hum Hypertens (2004) 0.95
Arterial baroreflexes and blood pressure and heart rate variabilities in humans. Hypertension (1986) 0.95
Dose-response curve and time course of the antihypertensive effect of SKF 92 657, a beta-receptor-blocking and vasodilating compound. Clin Sci (Lond) (1980) 0.95
Relationship between the hypotensive and renin-stimulating actions of diuretic therapy in hypertensive patients. Clin Sci Mol Med Suppl (1978) 0.94
Discussion on the natriuretic effect of calcium antagonists. J Cardiovasc Pharmacol (1987) 0.93
Ambulatory blood pressure, target organ damage and aortic root size in never-treated essential hypertensive patients. J Hum Hypertens (2007) 0.93
Diffuse and specific activation of sympathetic cholinergic fibers of the cat. Am J Physiol (1973) 0.93
Baroreceptor reflexes in human hypertension. Circ Res (1978) 0.92
Effects of single and repeated doses of the calcium antagonist felodipine on blood pressure, renal function, electrolytes and water balance, and renin-angiotensin-aldosterone system in hypertensive patients. J Cardiovasc Pharmacol (1987) 0.91
Reproducibility of nocturnal blood pressure fall in early phases of untreated essential hypertension: a prospective observational study. J Hum Hypertens (2004) 0.90
Vasomotor regulation during sleep in the cat. Am J Physiol (1971) 0.90
Effects of celiprolol on reflex control of the cardiovascular system in essential hypertension. J Cardiovasc Pharmacol (1986) 0.90
Multiple risk factors in hypertension: results from the Gubbio study. J Hypertens Suppl (1990) 0.90
Pulse pressure and isolated systolic hypertension: association with microalbuminuria. The GUBBIO Study Collaborative Research Group. Kidney Int (2000) 0.90
Ambulatory blood pressure normalcy: the PAMELA Study. J Hypertens Suppl (1991) 0.89
Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: results from the Assessment Prognostic Risk Observational Survey (APROS). J Hum Hypertens (2004) 0.89
Metabolic syndrome and left ventricular hypertrophy in a general population. Results from the Gubbio Study. J Hum Hypertens (2007) 0.89
Woven left coronary artery disease. Am J Cardiol (1995) 0.89
Reflex chemoceptive regulation of arterial pressure during natural sleep in the cat. Am J Physiol (1968) 0.89
Cardiovascular changes during naturally elicited fighting behavior in the cat. Am J Physiol (1969) 0.88
Reduced nocturnal fall in blood pressure, assessed by two ambulatory blood pressure monitorings and cardiac alterations in early phases of untreated essential hypertension. J Hum Hypertens (2003) 0.88
Prevalence of target organ damage in treated hypertensive patients: different impact of clinic and ambulatory blood pressure control. J Hypertens (2000) 0.87
Angiotensin converting enzyme inhibition in clinical practice. A re-examination of stepped-care: a retrospective and a prospective. J Cardiovasc Pharmacol (1985) 0.87
Antihypertensive therapy in patients above age 60 with systolic hypertension. A progress report of the European Working Party on High Blood Pressure in the Elderly (EWPHE). Clin Exp Hypertens A (1982) 0.87
Cardiovascular and renal effects of acute administration of a new hypotensive compound, guancydine. Eur J Clin Pharmacol (1971) 0.86
Verapamil and propranolol: a comparison of two antihypertensive agents. Acta Med Scand Suppl (1984) 0.86
Renal effects of calcium antagonists in hypertensive patients. J Hypertens Suppl (1985) 0.86
Systemic haemodynamic and humoral changes during urapidil treatment in hypertensive patients. J Hypertens Suppl (1988) 0.86
Regulation of vasopressin release in moderately severe essential hypertension. Clin Auton Res (1991) 0.86
Effects of antihypertensive treatment on vasopressin secretion and on its osmoregulation in moderate hypertension. J Hypertens (1997) 0.86
Neural control of circulation before and after intravenous urapidil in essential hypertension. Drugs (1988) 0.85
Effects of renal denervation on renin release in response to tilting and furosemide. Am J Physiol (1977) 0.85
Baroreflex sensitivity and its evolution during the first year after myocardial infarction. J Am Coll Cardiol (1988) 0.85
Hemodynamic patterns during desynchronized sleep in intact cats and in cats with sinoaortic deafferentation. Circ Res (1969) 0.85
Blood pressure control in a hypertension hospital clinic. J Hypertens (1999) 0.84
Clonidine and carotid baroreflex in essential hypertension. Hypertension (1980) 0.84
Isolated ambulatory hypertension and changes in target organ damage in treated hypertensive patients. J Hum Hypertens (2005) 0.84
Clinical trials on the treatment of hypertension. A critical appraisal. J Clin Hypertens (1986) 0.84
Angiotensin-converting enzyme inhibitors in essential hypertension. J Cardiovasc Pharmacol (1987) 0.84
Impact of nocturnal fall in blood pressure on early cardiovascular changes in essential hypertension. J Hypertens (1999) 0.84
Transient but not sustained blood pressure increments by occupational noise. An ambulatory blood pressure measurement study. J Hypertens (2001) 0.84
Evaluation of target organ damage in arterial hypertension: which role for qualitative funduscopic examination? Ital Heart J (2001) 0.84
Antihypertensive and water and sodium balance effects of felodipine, a new vasodilating calcium antagonist, in hypertensive patients. Drugs (1985) 0.84